Biden Administration Pause On Pending Trump-Era Rules Stalls FDA Cannabinoids Guidance Progress

 
• By Malcolm Spicer
The already long and winding road to FDA allowing lawful use of cannabinoids in non-drug products has become longer and more winding.

More from Cannabis/CBD

More from Ingredients & Safety